| Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring NJ Ashton, S Janelidze, N Mattsson-Carlgren, AP Binette, O Strandberg, ... Nature medicine 28 (12), 2555-2562, 2022 | 163 | 2022 |
| Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias CE Teunissen, L Kimble, S Bayoumy, K Bolsewig, F Burtscher, ... Molecular & Cellular Proteomics 22 (10), 2023 | 12 | 2023 |
| A model of epileptogenesis in Rhinal cortex-hippocampus organotypic slice cultures CA Valente, FJ Meda, M Carvalho, AM Sebastião JoVE (Journal of Visualized Experiments), e61330, 2021 | 6 | 2021 |
| Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid FJ Meda, K Knowles, IJ Swift, A Sogorb-Esteve, JD Rohrer, A Dittrich, ... BMJ Neurology Open 5 (1), 2023 | 5 | 2023 |
| NLRP3 inflammasome-driven neurodegeneration and epileptiform activity in a model of epileptogenesis in organotypic slices FJG Meda | 1 | 2021 |
| Analytical and clinical validation of a progranulin ELISA in the FTD disease spectrum F Meda, J Simrén, S Archetti, V Cantoni, U Andreasson, K Blennow, ... Alzheimer's & Dementia 19, e076093, 2023 | | 2023 |
| Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias F Meda, J Simrén, B Borroni, V Cantoni, S Archetti, G Biasiotto, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (12), 2195-2204, 2023 | | 2023 |
| TARGETING NLRP3 INFLAMMASOME: A NEW HOPE FOR EPILEPSY RESISTANCE ER Rocha, F Meda, A Sebastião, C Valente IBRO Neuroscience Reports 15, S252-S253, 2023 | | 2023 |
